On ECHEMI
Home > Drugs > Arteritis
Arteritis
Arteritis is a nonspecific panarteritis characterized by damage to the media. The entire artery layer shows diffuse irregular thickening and fibrosis, and the thickened intima proliferates into the lumen, causing arterial stenosis and obstruction.
Related Drugs
Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:

Zhejiang Deyer Pharmaceutical Co., Ltd.

Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:

Jiangsu Tasly DIYI Pharmaceutical Co., Ltd.

Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:

Penglai Nuokang Pharmaceutical Co., Ltd.

Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:

Shenzhen Neptunus Pharmaceutical Co., Ltd.

Cilostazol Tablets
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes; 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:

Zhejiang Kinglyuan Pharmaceutical Co., Ltd.

Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:

Zhejiang Yongning Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.